MYO9A
Basic information
Region (hg38): 15:71822291-72118577
Links
Phenotypes
GenCC
Source:
- myasthenic syndrome, congenital, 24, presynaptic (Strong), mode of inheritance: AR
- myasthenic syndrome, congenital, 24, presynaptic (Strong), mode of inheritance: AR
- myasthenic syndrome, congenital, 24, presynaptic (Limited), mode of inheritance: AR
- presynaptic congenital myasthenic syndrome (Supportive), mode of inheritance: AD
- myasthenic syndrome, congenital, 24, presynaptic (Limited), mode of inheritance: Unknown
- arthrogryposis syndrome (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myasthenic syndrome, congenital, 24, presynaptic | AR | Musculoskeletal; Neurologic | Individuals have been described as benefiting from medical management (with pyridostigmine and 3,4-DAP) | Musculoskeletal; Neurologic | 26752647; 27259756 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (304 variants)
- not_provided (99 variants)
- Myasthenic_syndrome,_congenital,_24,_presynaptic (27 variants)
- MYO9A-related_disorder (27 variants)
- Focal_segmental_glomerulosclerosis (4 variants)
- not_specified (2 variants)
- Bronchiectasis (2 variants)
- Flexion_contracture (2 variants)
- See_cases (2 variants)
- Presynaptic_congenital_myasthenic_syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYO9A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006901.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 35 | 47 | ||||
missense | 317 | 29 | 356 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 0 | 2 | 321 | 65 | 17 |
Highest pathogenic variant AF is 0.00000136885
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYO9A | protein_coding | protein_coding | ENST00000356056 | 41 | 296287 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.489 | 0.511 | 125569 | 1 | 178 | 125748 | 0.000712 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.74 | 1156 | 1.33e+3 | 0.866 | 0.0000709 | 16794 |
Missense in Polyphen | 278 | 414.05 | 0.67141 | 5226 | ||
Synonymous | -0.230 | 466 | 460 | 1.01 | 0.0000221 | 4745 |
Loss of Function | 8.31 | 30 | 134 | 0.224 | 0.00000811 | 1606 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00102 | 0.00102 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00530 | 0.00523 |
Finnish | 0.000186 | 0.000185 |
European (Non-Finnish) | 0.000230 | 0.000229 |
Middle Eastern | 0.00530 | 0.00523 |
South Asian | 0.000757 | 0.000719 |
Other | 0.00115 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Regulates Rho by stimulating it's GTPase activity in neurons, has a role in the regulation of neuronal morphology and function. {ECO:0000250|UniProtKB:Q9Z1N3}.;
- Pathway
- Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.0452
- rvis_EVS
- -0.7
- rvis_percentile_EVS
- 14.79
Haploinsufficiency Scores
- pHI
- 0.766
- hipred
- Y
- hipred_score
- 0.652
- ghis
- 0.568
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.831
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Myo9a
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- visual perception;bioluminescence;cell junction assembly;intracellular signal transduction;positive regulation of GTPase activity;establishment of epithelial cell apical/basal polarity;regulation of small GTPase mediated signal transduction
- Cellular component
- cytosol;integral component of membrane;unconventional myosin complex
- Molecular function
- motor activity;actin binding;GTPase activator activity;protein binding;ATP binding;metal ion binding